The firm posted a 20% increase in adjusted net income, reaching $1.03bn for the quarter ended 31 March. Fee-related earnings rose 23% to $822.6m, underscoring the stability of its business model during market dislocation. KKR's total AUM climbed to $664bn, supported by $31bn in capital raised. Co-CEO Scott Nuttall said the company is eyeing asset sales in Europe and Asia, regions that have been less impacted by US-driven tariff turbulence. With firms likely to seek debt capital in a choppy equity environment, KKR also stands to benefit through its credit platform. 'The opportunity is immense,' Nuttall said, pointing to further product launches aimed at retail investors. Earlier this week, KKR and Capital Group introduced two low-fee funds tailored to retail clients, with plans to roll out additional offerings in private equity, real estate, and infrastructure. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today....

The scheme requires a minimum net asset threshold of HK$30m over two years prior to application and an investment of the same amount into Permissible Investment Assets. These include a mandatory HK$3m contribution to a government-managed portfolio by the Hong Kong Investment Corporation and HK$27m across eligible public market securities, private funds, and non-residential real estate. Notably, the scheme allows for up to HK$10m to be invested in non-residential real estate, provided the property is fully owned by the applicant or their wholly owned company. Mortgages are permitted, though only the equity portion qualifies. Applicants must maintain investment thresholds for seven years, and profits may not be withdrawn apart from cash income like dividends or rent. The updated framework introduces greater flexibility than its predecessor, with permissible investments now extending to private limited partnership funds (LPFs) and open-ended fund companies, subject to defined caps. Early market reception suggests strong uptake. Banks, brokers, and fund sponsors are already fielding inquiries from global investors exploring pathways to establish investment structures and family offices under the New CIES....

It was a big week for the space and defense sectors, as investors clearly were looking to the skies. However, other sectors including cyber, healthcare and even data orchestration also saw some big raises. While nothing came close to $1 billion, it was still a pretty good week for big rounds. 1. Chaos Industries, $275M, defense: Less than six months after raising $145 million in a Series B, defense and critical infrastructure tech startup Chaos Industries locked up $275 million in a Series C that reportedly values the startup at $2 billion. The new round was led by Accel and New Enterprise Associates. Los Angeles-based Chaos specializes in advanced detection, monitoring and communication solutions for the defense and commercial sectors. The company's Vanquish radar provides early warning and tracking capabilities against unmanned aerial systems, missiles and aircraft. Founded in 2022, Chaos has raised $490 million, per the company. 2. True Anomaly, $260M, space: Centennial, Colorado-based True Anomaly, which develops hardware and software systems to help space security and readiness, is accustomed to large raises. Back in late 2023, the space tech startup raised a $100 million round led by Riot Ventures. It's back again after raising a $260 million Series C led by Accel. The startup helps the government and commercial customers keep an eye on threats to assets they have in space, such as satellites. Founded in 2022, True Anomaly has raised $418 million, per Crunchbase....

The fund, which has already secured nearly 50% of its target, continues MxEP's strategy of investing in early-stage healthcare companies across diagnostics, therapeutics, medtech, and pharma services. MI2 aims to back around 15 EU-based ventures, targeting scalable platform technologies with proof of concept, scientific strength, and reduced binary risk. Initial investments will typically be around '6m, with follow-ons potentially rising to '15m. 'With our continued Innovation strategy, we will target companies with a proof of concept and potential to scale and create value in the long term,' said Valerie Calenda, managing partner and head of Innovation. MI2's first investment supports deepull's '50m oversubscribed Series C round, co-led by Columbus Venture Partners, Panakes Partners, and Merieux Equity Partners. Other participants included Asabys Partners, Kurma Partners, and additional existing investors. Founded by Jordi Carrera and Rafel Bru'also co-founders of STAT-Dx (acquired by Qiagen in 2018)'deepull is developing a rapid, automated diagnostic platform capable of detecting nearly 300 pathogens and antimicrobial resistance genes directly from blood samples within one hour. The funding will help advance regulatory approvals and commercialisation....